Michael Rogers
Director/Board Member at AKEBIA THERAPEUTICS, INC.
Net worth: 175 733 $ as of 2024-03-30
Profile
Michael W.
Rogers is an Independent Director at Akebia Therapeutics, Inc. He previously served as the Chairman at Keryx Biopharmaceuticals, Inc. and as an Independent Director at Fortress Biotech, Inc., Aravive, Inc., EyePoint Pharmaceuticals, Inc., and Indevus Pharmaceuticals, Inc. He also held positions as Vice President-Investment Banking at Lehman Brothers, Inc. and PaineWebber, Inc. Additionally, he served as the Chief Financial Officer, Treasurer & Executive VP at Indevus Pharmaceuticals, Inc., AutoImmune, Inc., AHT Corp., Acorda Therapeutics, Inc., and BG Medicine, Inc. He obtained his undergraduate degree from Union College (New York) and an MBA from the University of Virginia Darden School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-06-05 | 96,029 ( 0.05% ) | 175 733 $ | 2024-03-30 | |
ARAVIVE, INC.
-.--% | 2023-08-02 | 0 ( -.--% ) | - $ | 2023-12-30 |
Michael Rogers active positions
| Companies | Position | Start |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Director/Board Member | 2018-12-11 |
Former positions of Michael Rogers
| Companies | Position | End |
|---|---|---|
| ARAVIVE, INC. | Director/Board Member | 2024-01-16 |
| AERPIO PHARMACEUTICALS | Director of Finance/CFO | 2019-10-14 |
| EYEPOINT PHARMACEUTICALS, INC. | Director/Board Member | 2019-05-31 |
| KERYX BIOPHARMACEUTICALS | Chairman | 2018-12-11 |
| ACORDA THERAPEUTICS, INC. | Director of Finance/CFO | 2016-10-03 |
Training of Michael Rogers
| Union College (New York) | Undergraduate Degree |
| University of Virginia Darden School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 6 |
|---|---|
| ACORDA THERAPEUTICS, INC. | Health Technology |
| BG MEDICINE, INC. | Health Technology |
| FORTRESS BIOTECH, INC. | Health Technology |
| EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Indevus Pharmaceuticals, Inc.
 Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Health Technology |
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Finance |
AutoImmune, Inc.
 AutoImmune, Inc. Pharmaceuticals: MajorHealth Technology AutoImmune, Inc. develop products to treat autoimmune and other cell-mediated inflammatory conditions. Its products are based on a biological mechanism known as oral tolerance, which provides tissue specific immunosuppression without toxicity or significant side effects. The company was founded in September 1988 and is headquartered in Pasadena, CA. | Health Technology |
AHT Corp.
 AHT Corp. Services to the Health IndustryHealth Services AHT Corp. is a national provider of Internet-based clinical e-commerce among physicians, other healthcare provides and healthcare organizations. The company is focused on automating laboratory and prescription transactions. Its products principally focus on laboratory and prescription connectivity and transaction processing, including within the laboratory suite of applications, Dr. Chart (R), Dr. Chart Web (TM), Compliance Monitor (TM), CDR (TM) and CDM (TM) and its electronic prescription writing product.. The company was founded by Edelson Jonathan on June 20, 1995 and is headquartered in Tarrytown, NY. | Health Services |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
| PaineWebber, Inc. | Finance |
Aerpio Pharmaceuticals, Inc.
 Aerpio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. The firm's product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial for the treatment of diabetic retinopathy. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; and AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed a single ascending dose clinical trial for the treatment of inflammatory bowel disease. The company was founded by Joseph H. Garder on November 16, 2007 and is headquartered in Cincinnati, OH. | Health Technology |
Apnimed, Inc.
 Apnimed, Inc. BiotechnologyHealth Technology Apnimed, Inc. operates as a clinical-stage company. It discovers novel pharmaceutical therapies for sleep apnea and related disorders. The company was founded by Lawrence G. Miller and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Michael Rogers
